Trial Profile
Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Darunavir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 28 Oct 2015 New trial record